|
⚲
|
| Keyboard |
| TCGX Asia Life Sciences Fund I LP | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002140843 |
| Sale | |
| Fund | Venture Capital Fund |
| Phone | 6509249424 |
| Address | 245 Lytton Ave, Suite 350 Palo Alto, CA 94301 |
| Source | [EDGAR] |
| Fund AUM and Sold ($) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-29 (D) |
| Exemption | 506(b), 3(c), 3(c)(7) |
| Remaining | $400,000,000 |
| Duration | One year or less |
| Revenue | Not Applicable |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Chen Yu | Director |
| Comparable Firms | State | AUM |
|---|---|---|
|
Activate Capital Management LP
✚
|
CA | |
|
Alsop Louie Management LLC
✚
|
CA | |
|
Cavalry Management Group LLC
✚
|
CA | |
|
Audacious Management Company LLC
✚
|
CA | |
|
Hayden Capital LLC
✚
|
CA | |
|
Headline Growth Management LLC
✚
|
CA | |
|
Initialized Capital Management LLC
✚
|
CA | |
|
Buckley Ventures Management Company LLC
✚
|
CA | |
|
Sutter Hill Ventures LLC
✚
|
CA | |
|
Notable Capital Management LLC
✚
|
CA |